Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ehexige Ehexige"'
Autor:
Ehexige Ehexige, Mingming Bao, Purevbat Bazarjav, Xiang Yu, Hai Xiao, Shuqin Han, Huricha Baigude
Publikováno v:
Biomolecules, Vol 10, Iss 2, p 285 (2020)
Cutaneous melanoma is the most aggressive skin cancer with notorious drug resistance. Inhibition of immune checkpoint molecules is one of the most promising approaches for cancer therapy. Herein, we show that RNAi mediated silencing of STAT3 expressi
Externí odkaz:
https://doaj.org/article/76f52d69c88c4639b16892968426069e
Publikováno v:
Molecules, Vol 24, Iss 18, p 3413 (2019)
Lipid nanoparticles (LNP) are the most potent carriers for the delivery of nucleic acid-based therapeutics. The first FDA approved a short interfering RNA (siRNA) drug that uses a cationic LNP system for the delivery of siRNA against human transthyre
Externí odkaz:
https://doaj.org/article/4bdf5251f6b049429eaf9465406f3e05
Autor:
Bao, Mingming, Ehexige, Ehexige, Xu, Jing, Ganbold, Tsogzolmaa, Han, Shuqin *, Baigude, Huricha *
Publikováno v:
In Carbohydrate Polymers 15 July 2021 264
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Carbohydrate polymers. 264
Curdlan activates dendritic cells (DCs) and enhances DC-based antitumor immunity. However, hydrophobicity and heterogeneity of curdlan particulates hinder perfect binding of curdlan to dectin-1 receptor, resulting in the reduced activation of antigen
Publikováno v:
Molecules
Volume 24
Issue 18
Molecules, Vol 24, Iss 18, p 3413 (2019)
Volume 24
Issue 18
Molecules, Vol 24, Iss 18, p 3413 (2019)
Lipid nanoparticles (LNP) are the most potent carriers for the delivery of nucleic acid-based therapeutics. The first FDA approved a short interfering RNA (siRNA) drug that uses a cationic LNP system for the delivery of siRNA against human transthyre
Autor:
Huricha Baigude, Hai Xiao, Mingming Bao, Ehexige Ehexige, Xiang Yu, Purevbat Bazarjav, Shuqin Han
Publikováno v:
Biomolecules
Biomolecules, Vol 10, Iss 2, p 285 (2020)
Volume 10
Issue 2
Biomolecules, Vol 10, Iss 2, p 285 (2020)
Volume 10
Issue 2
Cutaneous melanoma is the most aggressive skin cancer with notorious drug resistance. Inhibition of immune checkpoint molecules is one of the most promising approaches for cancer therapy. Herein, we show that RNAi mediated silencing of STAT3 expressi